Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
516.00
Ask:
520.00
Spread: 4.00 (0.775%)
Market Cap: £860.42m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Update from QuotedData

20 Dec 2023 09:39

RNS Number : 4677X
Oakley Capital Investments Limited
20 December 2023
Β 

Β 

Oakley Capital Investments - Update from QuotedData

20th December 2023

Walking the walk

Despite broader economic challenges, Oakley Capital Investments (OCI) continues to deliver outstanding, market beating shareholder returns. Its focus on cash-generative companies with recurring revenues and asset-light business models means the portfolio remains well insulated as financial conditions have tightened, highlighted by double digit earnings growth over the last financial year. The staggered nature of its investments has provided a consistent stream of realisations (at an average premium of 35%), validating net asset values (NAVs) and providing plenty of financial flexibility.

The latest of these was the Β£240m sale of its stake in IU group, which crystalised an 85% IRR. Despite this execution and market leading track record, shares remain at a considerable discount to NAV. While this reflects broader market weakness across unlisted assets, it is difficult to see how it can be justified over the long term given the strength of the company's NAV growth.

Full Research:

https://quoteddata.com/research/oakley-capital-investments-walking-walk-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Oakley Capital Investments and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

Β 

Β 

Β 

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAUROKROWUUURA
Date   Source Headline
15th Dec 20217:00 amRNSSale of TechInsights and follow-on investment
2nd Dec 202110:30 amEQSHardman Talks | Oakley Capital Investments Webinar: Everything you wanted to know about private equity but were afraid to ask!
1st Dec 202112:45 pmEQSHardman & Co: Hardman Talks Video Event | Oakley Capital Investments Live Q&A Webinar
25th Oct 20212:30 pmEQSHardman & Co Research: Q&A on Oakley Capital Investments (OCI) | Pipeline looks strong with new deals being announced regularly
21st Sep 20212:06 pmRNSDirector Dealing
14th Sep 20217:00 amRNSOakley Capital invests in Seedtag
13th Sep 20213:41 pmEQSHardman & Co Research: Oakley Capital Investments (OCI): 1H'21: 35% EBITDA growth drives 26% NAV return
9th Sep 20217:00 amRNSResults for the Six Months ended 30 June 2021
25th Aug 20217:00 amRNSNotice of Interim Results and Webcast Presentation
23rd Aug 20211:13 pmRNSHolding(s) in Company
13th Aug 20212:09 pmRNSHolding(s) in Company
12th Aug 202112:16 pmRNSHolding(s) in Company
2nd Aug 202112:37 pmRNSHolding(s) in Company
30th Jul 20215:57 pmRNSHolding(s) in Company
30th Jul 202111:29 amRNSHolding(s) in Company
29th Jul 20215:32 pmRNSTransaction in Own Shares
29th Jul 20217:00 amRNSShare Buy-Back Programme
28th Jul 20217:00 amRNSTrading Update for the Six Months Ended 30 June 21
27th Jul 20217:00 amRNSResult of AGM
21st Jul 202112:46 pmRNSHolding(s) in Company
1st Jul 202112:22 pmRNSChange of Administrator
29th Jun 20218:55 amRNSKepler Trust Intelligence: New Research
28th Jun 20217:00 amRNSSale of ACE Education and follow-on investment
28th Jun 20217:00 amRNSNotice of Annual General Meeting
24th Jun 20215:56 pmRNSHolding(s) in Company
24th Jun 20215:52 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSDirector Dealing
22nd Jun 20217:00 amRNSInvestment in Primavera
11th Jun 20217:30 amEQSHardman & Co Research: Hardman & Video | Q&A with Mark Thomas on Oakley Capital Investment (OCI)
7th Jun 20217:00 amRNSInvestment in Afterbuy and DreamRobot
3rd Jun 20214:50 pmRNSHolding(s) in Company
1st Jun 20217:00 amRNSInvestment in ICP Education
25th May 20211:40 pmEQSHardman & Co Research: Oakley Capital Investments (OCI): 2021 Capital Markets day: proof of the pudding
13th May 20215:25 pmRNSHolding(s) in Company
30th Apr 20214:29 pmRNSHolding(s) in Company
30th Apr 20213:29 pmRNSHolding(s) in Company
22nd Apr 20218:42 amRNSHolding(s) in Company
21st Apr 20217:00 amRNSCapital Markets Day
16th Apr 20213:54 pmRNSHolding(s) in Company
12th Apr 20214:03 pmRNSHolding(s) in Company
30th Mar 20219:10 amEQSHardman & Co Research : Hardman Talks Video | Oakley Capital Investments
22nd Mar 20219:30 amRNSHardman & Co: Sustained and sustainable NAV growth
15th Mar 20215:35 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
9th Mar 20212:05 pmEQSHardman & Co Research : Hardman Talks | Oakley Capital Investments Management Discussion
1st Mar 20217:00 amRNSRefinancing of Career Partner Group
23rd Feb 20217:00 amRNSNotice of Results and Investor Presentation
19th Feb 20217:00 amRNSInvestment in Dexters
10th Feb 20217:00 amRNSDirector Dealing
29th Jan 20214:42 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.